Synthio Labs just lit up the life sciences world with a $5M seed round that feels like the moment a quiet underground act gets handed the prime-time slot because the crowd already knows they are the real thing. Elevation Capital led the charge with Krishna Mehra calling the shot, backed by 1984 Ventures, Peak XV Partners, YC, and a lineup of strategic angels from global healthcare and AI. That kind of table forms only when the opportunity is too glaring to ignore and the team looks built for the long game.
Co-founder and CEO Supreet Deshpande comes in with the kind of resume that reads like someone who has been studying the pharma maze for years and finally decided to build the map himself. Co-founder and CPO Sahitya Sridhar brings technical depth sharpened through years building voice tech at scale. Co-founder and CTO Rajashekar Vasantha adds the applied science rigor forged at AWS and refined through NYU Data Science. It is a founding trio built with intention, precision, and just enough edge to take on a $1.7T industry that still treats communication like a part-time hobby.
Pharma spends 30B a year trying to engage clinicians and patients, yet most of it still feels like juggling paperwork in the dark. Synthio Labs saw the gap and built an AI OS designed to turn that fog into a functional ecosystem. Jarvis becomes the clinical-grade voice copilot for field teams who need speed, accuracy, and compliance in real time. Ather pulls voice, chat, and video into one intelligent connective tissue so every touchpoint feels coherent instead of stitched together. Simulation Studio creates high-fidelity digital twins of clinicians and patients so teams can model decisions, reactions, and strategy before they risk a single move in the real world.
Results are already showing. When Soteri Skin needed scale, Synthio Labs hit 5,000 patient calls in 48 hours with a voice AI that handled onboarding, screening, and support from start to finish. Founder and CEO Rafal Pielak made it clear the performance delivered above expectation. You do not automate thousands of eczema patient conversations at that pace unless the tech is engineered with clinical discipline and serious horsepower.
Krishna Mehra captured the moment perfectly. Synthio Labs is building the next major layer of customer engagement infrastructure for life sciences, a space with a global commercial footprint large enough to make even seasoned investors stop talking and start calculating. The opportunity is massive because the inefficiency is massive, and the team has the domain fluency to turn that gap into a defining advantage.
With fresh capital, Synthio Labs is scaling engineering, expanding across the US and Europe, and deepening partnerships with top-tier pharma teams. The mission sharpens with every deployment. Every clinician. Every patient. Every interaction. Synthio Labs is turning all of it into structured intelligence, compliant communication, and human-grade clarity at scale.
Startups Startup Funding Early Stage Venture Capital Seed Round AI Automation AI Voice Life sciences Healthcare Health Tech Infrastructure Technology Innovation Tech Ecosystem Startup Ecosystem Hiring Tech Hiring
